🔗 Visit the ClinicalTrials.gov page for NCT00126945
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15-25 years. | Vaccine | 2008 | 1.27 |
| 2 | Measurement of functional anti-meningococcal serogroup a activity using strain 3125 as the target strain for serum bactericidal assay. | Clin Vaccine Immunol | 2011 | 0.89 |
| 3 | Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience. | Adv Prev Med | 2011 | 0.88 |
| 4 | Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease. | Infect Drug Resist | 2014 | 0.86 |
| 5 | Routinely vaccinating adolescents against meningococcus: targeting transmission & disease. | Expert Rev Vaccines | 2016 | 0.75 |